•1 min read•from Science News
Some GLP-1 drugs are more effective for those with specific gene variants
Our take
Recent research has revealed that certain GLP-1 drugs demonstrate varying effectiveness based on specific gene variants within individuals. In a study, participants possessing gene variants in two particular genes experienced slightly greater weight loss when using GLP-1 medications. However, they also reported higher instances of nausea while using Zepbound. This finding underscores the importance of personalized medicine, highlighting how genetic factors can influence treatment outcomes and emphasizing the need for tailored approaches in obesity management. Understanding these dynamics is essential for optimizing therapeutic strategies.
In a study, people with gene variants in two genes lost slightly more weight on GLP-1 drugs, but threw up more on Zepbound.
Read on the original site
Open the publisher's page for the full experience
Tagged with
#GLP-1#drugs#gene variants#weight loss#study#Zepbound#genes#effectiveness#medication#pharmacogenomics#health#clinical trial#individual response#obesity#side effects#nausea#treatment#metabolism#therapeutics#personalized medicine